Key result
Hypertensive disorders of pregnancy linked to ~160% higher prevalence of metabolic syndrome.
Why the study?
Is metabolic syndrome more prevalent in hypertensive disorders of pregnancy and associated with adverse maternal-fetal outcomes?
Cohort (n=104)
Yes
Is metabolic syndrome more prevalent in hypertensive disorders of pregnancy and associated with adverse maternal-fetal outcomes?
Answers are grounded in this paper and cite their sources.
Metabolic syndrome is highly prevalent in women with hypertensive disorders of pregnancy and is associated with an increased risk of intrauterine growth restriction.
A bstract Background: Hypertensive disorders of pregnancy (HDP) profoundly affect maternal–fetal morbidity in Sub-Saharan Africa. Objectives: To determine the prevalence of metabolic syndrome (MetS) in HDP and its associated maternal–fetal outcomes. Materials and Methods: This hospital-based prospective cohort study was conducted at two tertiary care referral hospitals in Enugu, Nigeria, between January 2021 and June 2023. A total of 104 pregnant women were enrolled, comprising 52 women with HDP (exposed group) and 52 normotensive pregnant women (unexposed group). Participants were followed up prospectively until delivery to evaluate maternal and fetal outcomes. MetS was defined using pregnancy-adapted National Heart, Lung, and Blood Institute/American Heart Association and National Cholesterol Education Program Adult Treatment Panel III criteria. The participants were followed up throughout pregnancy according to the standard antenatal care protocols for high-risk and low-risk pregnancies. Maternal–fetal outcomes were collected from hospital folders, as recorded by the attending obstetrician. Descriptive statistics were used to determine the frequencies and percentages. The chi-square test and Pearson’s correlation were used to determine the associations. Fisher’s exact test was used to evaluate the association between MetS and unfavorable pregnancy outcomes in women with HDP. Results: MetS was significantly more prevalent among women with HDP (55.8%) compared with normotensive controls (21.2%; P < 0.001). Women with HDP exhibited significantly higher blood pressure, fasting blood glucose, triglyceride levels, and creatine kinase levels, alongside lower high-density lipoprotein cholesterol levels ( P < 0.001). The presence of MetS in HDP was associated with a significantly increased risk of intrauterine growth restriction (odds ratio = 4.40; P = 0.033), while other adverse maternal and fetal outcomes showed increased but nonsignificant risks ( P > 0.05). Conclusion: MetS is common among women with HDP in Enugu, Nigeria, and is associated with poorer maternal and fetal outcomes. Routine metabolic screening during antenatal care may facilitate early risk identification, guide clinical management, and improve pregnancy outcomes in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Obianyido et al. (2026) conducted a cohort in Hypertensive disorders of pregnancy (HDP) (n=104). Hypertensive disorders of pregnancy vs. Normotensive pregnancy was evaluated on Prevalence of metabolic syndrome (MetS) (p=< 0.001). Hypertensive disorders of pregnancy were associated with a higher prevalence of metabolic syndrome compared to normotensive controls.
Synapse has enriched 10 related papers. Consider them for comparative context: